These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 16571953)
1. Changing outcome from aneurysmal subarachnoid hemorrhage: another step closer. Warner DS; Laskowitz DT Anesthesiology; 2006 Apr; 104(4):629-30. PubMed ID: 16571953 [No Abstract] [Full Text] [Related]
2. Prognosis value of plasma S100B protein levels after subarachnoid aneurysmal hemorrhage. Weiss N; Sanchez-Peña P; Roche S; Beaudeux JL; Colonne C; Coriat P; Puybasset L Anesthesiology; 2006 Apr; 104(4):658-66. PubMed ID: 16571959 [TBL] [Abstract][Full Text] [Related]
3. S100B as an additional prognostic marker in subarachnoid aneurysmal hemorrhage. Sanchez-Peña P; Pereira AR; Sourour NA; Biondi A; Lejean L; Colonne C; Boch AL; Al Hawari M; Abdennour L; Puybasset L Crit Care Med; 2008 Aug; 36(8):2267-73. PubMed ID: 18596638 [TBL] [Abstract][Full Text] [Related]
4. Prognostic Value of Early S100 Calcium Binding Protein B and Neuron-Specific Enolase in Patients with Poor-Grade Aneurysmal Subarachnoid Hemorrhage: A Pilot Study. Abboud T; Mende KC; Jung R; Czorlich P; Vettorazzi E; Priefler M; Kluge S; Westphal M; Regelsberger J World Neurosurg; 2017 Dec; 108():669-675. PubMed ID: 28943424 [TBL] [Abstract][Full Text] [Related]
6. Effect of magnesium sulfate therapy on patients with aneurysmal subarachnoid hemorrhage using serum S100B protein as a prognostic marker. Hassan T; Nassar M; Elhadi SM; Radi WK Neurosurg Rev; 2012 Jul; 35(3):421-7; discussion 427. PubMed ID: 22170177 [TBL] [Abstract][Full Text] [Related]
7. The Role of ABO Blood Group in Cerebral Vasospasm, Associated Intracranial Hemorrhage, and Delayed Cerebral Ischemia in 470 Patients with Subarachnoid Hemorrhage. Dubinski D; Won SY; Konczalla J; Mersmann J; Geisen C; Herrmann E; Seifert V; Senft C World Neurosurg; 2017 Jan; 97():532-537. PubMed ID: 27777156 [TBL] [Abstract][Full Text] [Related]
8. Atorvastatin decreases computed tomography and S100-assessed brain ischemia after subarachnoid aneurysmal hemorrhage: a comparative study. Sanchez-Peña P; Nouet A; Clarençon F; Colonne C; Jean B; Le Jean L; Fonfrede M; Aout M; Vicaut E; Puybasset L Crit Care Med; 2012 Feb; 40(2):594-602. PubMed ID: 21926584 [TBL] [Abstract][Full Text] [Related]
9. Statins as neuroprotectants after subarachnoid hemorrhage. Bhardwaj A Crit Care Med; 2012 Feb; 40(2):695-7. PubMed ID: 22249060 [No Abstract] [Full Text] [Related]
10. The prognostic value of NSE and S100B from serum and cerebrospinal fluid in patients with spontaneous subarachnoid hemorrhage. Moritz S; Warnat J; Bele S; Graf BM; Woertgen C J Neurosurg Anesthesiol; 2010 Jan; 22(1):21-31. PubMed ID: 20027011 [TBL] [Abstract][Full Text] [Related]
11. Delayed progressive restenosis of the supraclinoid internal carotid artery treated with percutaneous transluminal angioplasty in a patient with aneurysmal subarachnoid hemorrhage. Hsu DP; Hu YC; Bambakidis NC J Neurointerv Surg; 2009 Dec; 1(2):175-8. PubMed ID: 21994293 [TBL] [Abstract][Full Text] [Related]
12. Comparison of plasma copeptin and multiple biomarkers for assessing prognosis of patients with aneurysmal subarachnoid hemorrhage. Zheng YK; Dong XQ; Du Q; Wang H; Yang DB; Zhu Q; Che ZH; Shen YF; Jiang L; Hu W; Wang KY; Yu WH Clin Chim Acta; 2017 Dec; 475():64-69. PubMed ID: 29037840 [TBL] [Abstract][Full Text] [Related]
13. An admission bioclinical score to predict 1-year outcomes in patients undergoing aneurysm coiling. Degos V; Apfel CC; Sanchez P; Colonne C; Renuit I; Clarençon F; Nouet A; Boch AL; Pourmohamad T; Kim H; Gourraud PA; Young WL; Puybasset L Stroke; 2012 May; 43(5):1253-9. PubMed ID: 22363051 [TBL] [Abstract][Full Text] [Related]
14. The use of S100B as a biomarker in subarachnoid hemorrhage: clarity in its promise and limits. Laskowitz DT; Warner DS Crit Care Med; 2008 Aug; 36(8):2452-3. PubMed ID: 18664797 [No Abstract] [Full Text] [Related]
15. Endovascular treatment of intracranial aneurysms and vasospasm after aneurysmal subarachnoid hemorrhage. Hanel RA; Lopes DK; Wehman JC; Sauvageau E; Levy EI; Guterman LR; Hopkins LN Neurosurg Clin N Am; 2005 Apr; 16(2):317-53, ix. PubMed ID: 15694165 [No Abstract] [Full Text] [Related]
16. S-100B and NSE: markers of initial impact of subarachnoid haemorrhage and their relation to vasospasm and outcome. Oertel M; Schumacher U; McArthur DL; Kästner S; Böker DK J Clin Neurosci; 2006 Oct; 13(8):834-40. PubMed ID: 16931022 [TBL] [Abstract][Full Text] [Related]
17. Triple H therapy after aneurysmal subarachnoid hemorrhage. A review. Romner B; Reinstrup P Acta Neurochir Suppl; 2001; 77():237-41. PubMed ID: 11563296 [No Abstract] [Full Text] [Related]
18. Which treatment modality is more injurious to the brain in patients with subarachnoid hemorrhage? Degree of brain damage assessed by serum S100 protein after aneurysm clipping or coiling. Shim JH; Yoon SM; Bae HG; Yun IG; Shim JJ; Lee KS; Doh JW Cerebrovasc Dis; 2012; 34(1):38-47. PubMed ID: 22759541 [TBL] [Abstract][Full Text] [Related]
19. Increased GFAP and S100beta but not NSE serum levels after subarachnoid haemorrhage are associated with clinical severity. Vos PE; van Gils M; Beems T; Zimmerman C; Verbeek MM Eur J Neurol; 2006 Jun; 13(6):632-8. PubMed ID: 16796588 [TBL] [Abstract][Full Text] [Related]
20. Adrenomedullin in patients with cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Fujioka M; Nishio K; Sakaki T; Minamino N; Kitamura K Stroke; 2000 Dec; 31(12):3079-83. PubMed ID: 11108778 [No Abstract] [Full Text] [Related] [Next] [New Search]